Search
for
Sort by
Research 31–60 of 759
- Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Hidradenitis suppurativa and major adverse cardiac events: A systematic review and meta-analysis
- Reporting on Adverse Clinical Events
- Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017
- Anabolic androgenic steroids impact on cardiovascular risk and cardiovascular events. The literature review
- Combined hormonal contraception and venous thromboembolism
- Endocrinology of Transgender Medicine
- Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case–control analysis using German claims data
- Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey
- Family planning 2011: better use of existing methods, new strategies and more informed choices for female contraception
- Women’s Health Considerations for Lipid Management
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
- Contraception and the dermatologist
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Acne in the adult female patient: a practical approach
- What does the research say about androgen use and cerebrovascular events?
- Treatment of hyperandrogenism in polycystic ovary syndrome
- Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients
- A Review of hormone-based therapies to treat adult acne vulgaris in women
- Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20–59 Years in the United Kingdom’s CPRD 1995–2015
- Hormonal contraceptives: pharmacology tailored to women's health
- Contraceptive use in acne
- Cultural Sensitivity and Challenges in Management of the Transgender Patient With ESRD in Transplantation
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- Alopecia areata does not increase the risk of venous thromboembolism: an All of Us case-control study